EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN
This paper shows the research results of the biological therapy with chimeric monoclonal antibody to tumor necrosis factor (TNF) (infliximab). 33 children aged 6 to 18 years with various forms of Crohn’s disease were enrolled in the study. Therapy duration ranged from 3 months to 1 year or more. Af...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2012-01-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839575613981065216 |
|---|---|
| author | E. G. Tsimbalova A. S. Potapov M. M. Venedictova F. F. Shavrov |
| author_facet | E. G. Tsimbalova A. S. Potapov M. M. Venedictova F. F. Shavrov |
| author_sort | E. G. Tsimbalova |
| collection | DOAJ |
| description | This paper shows the research results of the biological therapy with chimeric monoclonal antibody to tumor necrosis factor (TNF) (infliximab). 33 children aged 6 to 18 years with various forms of Crohn’s disease were enrolled in the study. Therapy duration ranged from 3 months to 1 year or more. After the induction course of therapy efficacy was 94%, clinical remission was achieved in 70% of patients, after 1 year of therapy efficacy of therapy was reduced to 84%, clinical remission was observed in 70% of children. Endoscopic remission rate after induction was observed in 24% of children, and in 29% after 54 weeks of therapy. After one year of treatment in 9 out of 11 children glucocorticoid therapy was completely stopped. Adverse events after infliximab administration were observed in 9% of children. One child was withdrawn from the study due to infliximab intolerance. |
| format | Article |
| id | doaj-art-3e590e19d7a44e90a84e07f52e206e10 |
| institution | Matheson Library |
| issn | 1682-5527 1682-5535 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj-art-3e590e19d7a44e90a84e07f52e206e102025-08-04T13:09:27Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352012-01-0111113514210.15690/vsp.v11i1.145523EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDRENE. G. Tsimbalova0A. S. Potapov1M. M. Venedictova2F. F. Shavrov3Scientific Research Center of Children’s Health RAMS, MoscowScientific Research Center of Children’s Health RAMS, Moscow; I.M. Sechenov First Moscow State Medical University, MoscowScientific Research Center of Children’s Health RAMS, MoscowScientific Research Center of Children’s Health RAMS, MoscowThis paper shows the research results of the biological therapy with chimeric monoclonal antibody to tumor necrosis factor (TNF) (infliximab). 33 children aged 6 to 18 years with various forms of Crohn’s disease were enrolled in the study. Therapy duration ranged from 3 months to 1 year or more. After the induction course of therapy efficacy was 94%, clinical remission was achieved in 70% of patients, after 1 year of therapy efficacy of therapy was reduced to 84%, clinical remission was observed in 70% of children. Endoscopic remission rate after induction was observed in 24% of children, and in 29% after 54 weeks of therapy. After one year of treatment in 9 out of 11 children glucocorticoid therapy was completely stopped. Adverse events after infliximab administration were observed in 9% of children. One child was withdrawn from the study due to infliximab intolerance.https://vsp.spr-journal.ru/jour/article/view/523childrencrohn’s diseasetreatment with infliximab |
| spellingShingle | E. G. Tsimbalova A. S. Potapov M. M. Venedictova F. F. Shavrov EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN Вопросы современной педиатрии children crohn’s disease treatment with infliximab |
| title | EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN |
| title_full | EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN |
| title_fullStr | EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN |
| title_full_unstemmed | EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN |
| title_short | EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN |
| title_sort | efficacy ofinfliximabin the treatmentof crohn s diseasein children |
| topic | children crohn’s disease treatment with infliximab |
| url | https://vsp.spr-journal.ru/jour/article/view/523 |
| work_keys_str_mv | AT egtsimbalova efficacyofinfliximabinthetreatmentofcrohnsdiseaseinchildren AT aspotapov efficacyofinfliximabinthetreatmentofcrohnsdiseaseinchildren AT mmvenedictova efficacyofinfliximabinthetreatmentofcrohnsdiseaseinchildren AT ffshavrov efficacyofinfliximabinthetreatmentofcrohnsdiseaseinchildren |